Online citations, reference lists, and bibliographies.

Breast MRI Radiogenomics: Current Status And Research Implications.

Lars J. Grimm
Published 2016 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
Breast magnetic resonance imaging (MRI) radiogenomics is an emerging area of research that has the potential to directly influence clinical practice. Clinical MRI scanners today are capable of providing excellent temporal and spatial resolution, which allows extraction of numerous imaging features via human extraction approaches or complex computer vision algorithms. Meanwhile, advances in breast cancer genetics research has resulted in the identification of promising genes associated with cancer outcomes. In addition, validated genomic signatures have been developed that allow categorization of breast cancers into distinct molecular subtypes as well as predict the risk of cancer recurrence and response to therapy. Current radiogenomics research has been directed towards exploratory analysis of individual genes, understanding tumor biology, and developing imaging surrogates to genetic analysis with the long-term goal of developing a meaningful tool for clinical care. The background of breast MRI radiogenomics research, image feature extraction techniques, approaches to radiogenomics research, and promising areas of investigation are reviewed. J. Magn. Reson. Imaging 2016;43:1269-1278.
This paper references
10.4137/BIC.S9455
Molecular Profiling for Breast Cancer: A Comprehensive Review
Muaiad Kittaneh (2013)
BI-RADS: magnetic resonance imaging
DM Ikeda (2013)
10.1001/jama.295.21.2492
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.
Lisa A. Carey (2006)
10.1016/j.semradonc.2009.05.004
Breast cancer molecular subtypes in patients with locally advanced disease: impact on prognosis, patterns of recurrence, and response to therapy.
Kathryn E. Huber (2009)
NF - kappaB protein expression associates with ( 18 ) F - FDG PET tumor uptake in non - small
VS Nair
10.1002/jmri.24519
Correlations between apparent diffusion coefficient values of invasive ductal carcinoma and pathologic factors on diffusion-weighted MRI at 3.0 Tesla.
Sung Hee Park (2015)
10.32388/wgy03s
American society of clinical oncology.
Walter Alexander (2008)
10.1016/j.cmpb.2008.08.005
MaZda - A software package for image texture analysis
Piotr M. Szczypinski (2009)
10.1016/j.rcl.2007.06.008
The probably benign assessment.
Jessica W T Leung (2007)
10.1038/nature08975
Long noncoding RNA HOTAIR reprograms chromatin state to promote cancer metastasis
Rajnish A. Gupta (2010)
10.1109/TMI.2012.2219589
A Multichannel Markov Random Field Framework for Tumor Segmentation With an Application to Classification of Gene Expression-Based Breast Cancer Recurrence Risk
Ahmed Bilal Ashraf (2013)
10.1007/s00330-015-3845-6
Magnetic resonance imaging texture analysis classification of primary breast cancer
Shelley A. Waugh (2015)
10.1016/j.ejrad.2008.05.007
Prognostic value of pre-treatment DCE-MRI parameters in predicting disease free and overall survival for breast cancer patients undergoing neoadjuvant chemotherapy.
Martin D. Pickles (2009)
10.1109/TSMC.1973.4309314
Textural Features for Image Classification
Robert M. Haralick (1973)
10.1016/j.jacr.2015.04.019
Radiogenomics: what it is and why it is important.
Maciej A. Mazurowski (2015)
10.1016/j.ctrv.2013.06.006
Breast cancer classification by proteomic technologies: current state of knowledge.
Siu W. Lam (2014)
10.1148/radiol.13130663
Radiogenomics of clear cell renal cell carcinoma: associations between CT imaging features and mutations.
Christoph Alexander Karlo (2014)
10.1148/radiol.14140594
Can breast cancer molecular subtype help to select patients for preoperative MR imaging?
Lars J. Grimm (2015)
10.1186/bcr2124
Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures
Pratyaksha Wirapati (2008)
10.1093/annonc/mdt303
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
Aron Goldhirsch (2013)
10.1158/0008-5472.CAN-07-5644
Subtypes of breast cancer show preferential site of relapse.
Marcel Smid (2008)
10.1148/radiol.13132195
Behind the numbers: Decoding molecular phenotypes with radiogenomics--guiding principles and technical considerations.
Michael D. Kuo (2014)
10.1093/annonc/mds586
Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group Statement.
Sévérine Guiu (2012)
10.1016/j.ejrad.2015.07.012
Recurrence-free survival in breast cancer is associated with MRI tumor enhancement dynamics quantified using computer algorithms.
Maciej A. Mazurowski (2015)
10.1016/J.BREASTDIS.2015.10.008
Identification of Intrinsic Imaging Phenotypes for Breast Cancer Tumors: Preliminary Associations with Gene Expression Profiles
Kayoung Shin (2015)
10.1586/era.10.91
Multigene assays and isolated tumor cells for early breast cancer treatment: time for bionetworks
Dimitrios H Roukos (2010)
10.1158/1078-0432.CCR-06-1109
The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes
Lisa A. Carey (2007)
10.1016/j.nic.2014.09.010
Imaging genomics of Glioblastoma: state of the art bridge between genomics and neuroradiology.
Mohamed G Elbanan (2015)
10.1097/COC.0000000000000123
Hepatocellular carcinoma: can circulating tumor cells and radiogenomics deliver personalized care?
Richard L Hesketh (2015)
10.1200/JCO.2007.14.2364
American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer.
Lyndsay N. Harris (2007)
NF-kappaB protein expression associates with (18)F-FDG PET tumor uptake in nonsmall cell lung cancer: a radiogenomics validation study to understand tumor metabolism. Lung Cancer 2014;83:189–196
VS Nair (2014)
10.1148/radiol.14131375
Identification of intrinsic imaging phenotypes for breast cancer tumors: preliminary associations with gene expression profiles.
Ahmed Bilal Ashraf (2014)
10.1016/j.tranon.2014.07.007
NCI Workshop Report: Clinical and Computational Requirements for Correlating Imaging Phenotypes with Genomics Signatures
Rivka R. Colen (2014)
10.3892/ol.2012.1004
Analysis of complete response by MRI following neoadjuvant chemotherapy predicts pathological tumor responses differently for molecular subtypes of breast cancer.
Yuji Hayashi (2013)
10.1073/pnas.191367098
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
Therese Sørlie (2001)
Clustering approaches to identifying gene expression patterns from DNA microarray data.
Jin Hwan Do (2008)
10.1002/jmri.24884
MRI phenotype of breast cancer: Kinetic assessment for molecular subtypes.
Eric M Blaschke (2015)
10.1016/j.lungcan.2013.11.001
NF-κB protein expression associates with (18)F-FDG PET tumor uptake in non-small cell lung cancer: a radiogenomics validation study to understand tumor metabolism.
Viswam S. Nair (2014)
10.3322/canjclin.57.2.75
American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography
Debbie Saslow (2007)
10.3816/CBC.2007.n.012
Analysis of the pathologic response to primary chemotherapy in patients with locally advanced breast cancer grouped according to estrogen receptor, progesterone receptor, and HER2 status.
Luís Fernández-Morales (2007)
10.2214/AJR.14.13666
Breast cancer molecular subtype as a predictor of the utility of preoperative MRI.
Richard Ha (2015)
Texture analysis methodologies for magnetic resonance imaging
Andrzej Materka (2004)
ACR practice parameter for the performance of contrast-enhanced mangnetic resonance imaging (MRI) of the breast
MC Mahoney (2014)
10.1002/jmri.24934
Histogram analysis of apparent diffusion coefficient at 3.0t: Correlation with prognostic factors and subtypes of invasive ductal carcinoma.
Eun Jeong Kim (2015)
10.6004/jnccn.2014.0058
Breast cancer version 3.2014.
William John Gradishar (2014)
10.1038/35021093
Molecular portraits of human breast tumours
Charles M. Perou (2000)
10.1016/S0166-4328(01)00297-2
Controlling the false discovery rate in behavior genetics research
Yoav Benjamini (2001)
10.1016/j.ejrad.2009.01.050
Radiogenomics: creating a link between molecular diagnostics and diagnostic imaging.
Aaron M Rutman (2009)
10.1002/jmri.24890
Breast cancer subtype intertumor heterogeneity: MRI-based features predict results of a genomic assay.
Elizabeth J. Sutton (2015)
10.1148/radiol.15142698
Breast Cancer: Radiogenomic Biomarker Reveals Associations among Dynamic Contrast-enhanced MR Imaging, Long Noncoding RNA, and Metastasis.
Shota Yamamoto (2015)
Texture Analysis Methods - A Review
Andrzej Materka (1998)
10.1016/j.breast.2007.07.014
Pre-operative staging of breast cancer with breast MRI: one step forward, two steps back?
Christiane K. Kuhl (2007)
10.1186/bcr2904
Luminal-B breast cancer and novel therapeutic targets
Ben Tran (2011)
10.1007/s00330-012-2403-8
Correlations between diffusion-weighted imaging and breast cancer biomarkers
Laura Martincich (2012)
10.1148/radiol.13121801
Survival outcomes of breast cancer patients who receive neoadjuvant chemotherapy: association with dynamic contrast-enhanced MR imaging with computer-aided evaluation.
Ann Yi (2013)
10.1007/s12282-013-0512-0
Intratumoral heterogeneity of the distribution of kinetic parameters in breast cancer: comparison based on the molecular subtypes of invasive breast cancer
Ken Yamaguchi (2014)
10.1200/JCO.2007.14.5565
Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group.
Marianne Kyndi (2008)
10.2147/CEOR.S53142
Cost-effectiveness analysis of Mammostrat® compared with Oncotype DX® to inform the treatment of breast cancer
Kimberly Mislick (2014)
10.1200/JCO.2001.19.6.1865
2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology.
Robert C. Bast (2001)
10.1148/radiol.2442051620
The current status of breast MR imaging. Part I. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice.
Christiane K. Kuhl (2007)
10.1102/1470-7330.2006.0021
Diffusion-weighted magnetic resonance imaging and its application to cancer
Elizabeth M. Charles-Edwards (2006)
10.1148/radiol.14132641
Radiogenomic analysis of breast cancer: luminal B molecular subtype is associated with enhancement dynamics at MR imaging.
Maciej A. Mazurowski (2014)
10.1186/bcr2923
'Omic approaches to preventing or managing metastatic breast cancer
Obi L. Griffith (2011)
10.2214/AJR.11.7824
Radiogenomic analysis of breast cancer using MRI: a preliminary study to define the landscape.
Shota Yamamoto (2012)
10.12659/MSM.892534
Parameters of Dynamic Contrast-Enhanced MRI as Imaging Markers for Angiogenesis and Proliferation in Human Breast Cancer
Lin Li (2015)
10.1002/jmri.24879
Computational approach to radiogenomics of breast cancer: Luminal A and luminal B molecular subtypes are associated with imaging features on routine breast MRI extracted using computer vision algorithms.
Lars J. Grimm (2015)



This paper is referenced by
10.1016/j.ejrad.2019.108782
Differentiation between idiopathic granulomatous mastitis and invasive breast carcinoma, both presenting with non-mass enhancement without rim-enhanced masses: The value of whole-lesion histogram and texture analysis using apparent diffusion coefficient.
Qiufeng Zhao (2019)
10.1007/978-3-319-42563-4_17
Personalized Medicine, Biomarkers of Risk and Breast MRI
Elizabeth J. Sutton (2017)
10.1007/s00117-018-0409-1
Imaging and the completion of the omics paradigm in breast cancer
Doris Leithner (2018)
10.18632/oncotarget.24893
Non-invasive tumor genotyping using radiogenomic biomarkers, a systematic review and oncology-wide pathway analysis
Robin W Jansen (2018)
10.1117/12.2294056
A deep learning classifier for prediction of pathological complete response to neoadjuvant chemotherapy from baseline breast DCE-MRI
Kavya Ravichandran (2018)
10.1186/s41747-017-0025-2
Breast MRI radiomics: comparison of computer- and human-extracted imaging phenotypes
Elizabeth J. Sutton (2017)
10.1007/s10549-017-4143-6
MR imaging features associated with distant metastasis-free survival of patients with invasive breast cancer: a case–control study
Sung Eun Song (2017)
10.1634/theoncologist.2019-0427
Lymph Node Imaging in Patients with Primary Breast Cancer: Concurrent Diagnostic Tools
Maria Adele Marino (2020)
10.1088/1361-6560/ab3fd3
Integration of dynamic contrast-enhanced magnetic resonance imaging and T2-weighted imaging radiomic features by a canonical correlation analysis-based feature fusion method to predict histological grade in ductal breast carcinoma.
Ming Fan (2019)
10.2214/AJR.17.18708
Biomarkers and Imaging of Breast Cancer.
Olena Weaver (2018)
10.3174/ajnr.A5899
MR Imaging–Based Radiomic Signatures of Distinct Molecular Subgroups of Medulloblastoma
Michael Iv (2019)
10.1212/WNL.0000000000009490
Correlation between NF1 genotype and imaging phenotype on whole-body MRI
Yunpeng Liu (2020)
10.1016/j.ejrad.2019.108711
Mammography-based radiomic analysis for predicting benign BI-RADS category 4 calcifications.
Chuqian Lei (2019)
10.1016/j.acra.2017.08.009
Apparent Diffusion Coefficient Value to Evaluate Tumor Response After Neoadjuvant Chemotherapy in Patients with Breast Cancer.
Yazmín Aseret Ramírez-Galván (2018)
10.1007/s11307-019-01423-5
Contrast-Enhanced Mammography and Radiomics Analysis for Noninvasive Breast Cancer Characterization: Initial Results
Maria Adele Marino (2019)
10.1002/jmri.25870
Background, current role, and potential applications of radiogenomics
Katja Pinker (2018)
10.1148/radiol.2017162853
Intravoxel Incoherent Motion and Quantitative Non-Gaussian Diffusion MR Imaging: Evaluation of the Diagnostic and Prognostic Value of Several Markers of Malignant and Benign Breast Lesions.
Mami Iima (2018)
10.21147/j.issn.1000-9604.2020.02.05
Evaluation of human epidermal growth factor receptor 2 status of breast cancer using preoperative multidetector computed tomography with deep learning and handcrafted radiomics features
Xiaojun Yang (2020)
10.3389/fonc.2019.00505
Machine Learning-Based Analysis of MR Multiparametric Radiomics for the Subtype Classification of Breast Cancer
Tianwen Xie (2019)
10.1016/J.EJRAD.2019.02.022
Radiogenomics of rectal adenocarcinoma in the era of precision medicine: A pilot study of associations between qualitative and quantitative MRI imaging features and genetic mutations.
Natally Horvat (2019)
10.1002/jmri.27026
Synchronous Breast Cancer: Phenotypic Similarities on MRI
Hui Wang (2019)
10.1007/978-3-319-94878-2_14
Deep Learning in Breast Cancer Screening
Hugh Harvey (2019)
10.1371/journal.pone.0171683
Radiomic analysis reveals DCE-MRI features for prediction of molecular subtypes of breast cancer
Ming Fan (2017)
10.1002/jmri.26058
Imaging biomarkers in oncology: Basics and application to MRI
Isabel Dregely (2018)
10.1007/s00330-017-4850-8
Interim heterogeneity changes measured using entropy texture features on T2-weighted MRI at 3.0 T are associated with pathological response to neoadjuvant chemotherapy in primary breast cancer
Shelley A. Henderson (2017)
Semantic Scholar Logo Some data provided by SemanticScholar